← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
ADCBBiologicMerck Sharp & Dohme LLCPhase 2

Cytoxan (Cytoxan)

Multiple Myeloma, Refractory · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 73상태 RECRUITING
ADCBBiologicTheRas, Inc., dPhase 2

mFOLFOX6 (mFOLFOX6)

Non-Small Cell Lung Cancer; NSCLC · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.64%임상시험 71상태 RECRUITING
ADCSBiologicShanghai Juncell TherapeuticsApproved

Hydroxychloroquine (Hydroxychloroquine)

Psoriasis; Atopic Dermatitis · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 75%임상시험 70상태 ACTIVE
AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab & Ipilimumab)

Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell Carcinoma · Prostate Cancer

#ProstateCancer#Antibody#Phase2#인기#항체+5
효능 ORR 61.3%임상시험 70상태 ACTIVE
ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue Medication (Rescue Medication)

Non Small Cell Lung Cancer · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase3#인기#항체약물접합체+3
임상시험 69상태 RECRUITING
ADCBiologicPfizerPhase 2

Binimetinib (Binimetinib)

Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 66.7%임상시험 68상태 RECRUITING
ADCBiologicUNICANCERPhase 2

Epirubicin hydrochloride (Epirubicin hydrochloride)

Breast Cancer · Breast Neoplasms

#BreastNeoplasms#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 43.3%임상시험 68상태 RECRUITING
ADCBiologicHoffmann-La Rochevedotin (ARON-2EV study)Approved

Platinum Based Chemotherapy (Platinum Based Chemotherapy)

Non-Squamous Non-Small Cell Lung Cancer · Ovarian Cancer

#OvarianCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 66%임상시험 68상태 RECRUITING
ADCBiologicSpanish Breast Cancer Research …sPhase 2

Taxotere (Taxotere)

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 88.1%임상시험 68상태 RECRUITING
ADCBiologicJanssen Research & Development,…Phase 1

Abiraterone acetate (Abiraterone acetate)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 46%임상시험 67상태 RECRUITING
ADCBiologicRocheDM1 via butelase-1 with ABD…Phase 2

trastuzumab (Herceptin, Ado-trastuzumab, Ado-trastuzumab (T) emtansine (T-DM1))

Salivary Gland Cancer; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 74.1%임상시험 67상태 RECRUITING
ADCBiologicAstellasvedotin (ARON-2EV study)Phase 2

EV (Enfortumab vedotin-ejfv, Enfortumab vedotin-ejfv (EV))

Urothelial Cancer; Metastatic Urothelial Carcinoma · Urothelial Cancer

#UrothelialCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 67상태 RECRUITING
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Carboplatin (Pemetrexed/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 87.5%임상시험 67상태 RECRUITING
AntibodyShanghai Shengdi Pharmaceutical…vedotin (RC48) in combinati…Phase 2

Adebrelimab (Adebrelimab)

Pancreatic Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#인기#항체+5
임상시험 66상태 RECRUITING
ADCBiologicAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 75%임상시험 66상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicPfizerderuxtecan improved objecti…Phase 2

Encorafenib (Encorafenib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue medications (Rescue medications)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 66상태 RECRUITING
ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 66.7%임상시험 66상태 RECRUITING

4 / 75 페이지

← 이전다음 →